See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
The Oscars
Volodymyr Zelenskyy
Ukraine War
Academy Awards
Social Media
Artificial Intelligence
Baseball
Donald Trump
Basketball
Tariffs
Athletics
European Union
Published • loading... • Updated

Patients struggle with lack of consistent coverage for popular weight-loss drugs

  • Many employers and insurers are reducing coverage for Wegovy and Zepbound, with Medicare not covering obesity treatments at all.
  • Paul Mack lost coverage of Wegovy, illustrating the inconsistent access to essential medications.
  • Health care experts warn that there's no guarantee employers will benefit from covering these drugs due to job changes.
  • Katherine Hempstead emphasized the urgent need for people to access these medications, highlighting a significant gap in treatment provision.
Insights by Ground AI
Does this summary seem wrong?

13 Articles

All
Left
5
Center
4
Right
1
NBC ChicagoNBC Chicago

Consumer Reports: Are weight loss drugs safe for older adults?

Weight loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and potential health benefits. While the outcomes can be positive, Consumer Reports warns there are important considerations, especially for older adults, before starting these treatments. Crystal Garcia said her doctor prescribed an injectable GLP-1 medication to help her lose weight. “He is like, ‘We can try this medication,” Garc…

·Chicago, United States
Read Full Article
Arkansas BusinessArkansas Business

Yearslong Shortage of Popular Weight-Loss and Diabetes Drugs Is Resolved, FDA Says

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments continue to improve, federal regulators said Friday. The drugmaker Novo Nordisk can meet current and future demand in the U.S., the Food and Drug Administration said. But patients may still see some supply disruptions as the medications move from the manufacturer to distributors and then t…

Read Full Article
Associated Press NewsAssociated Press News
+8 Reposted by 8 other sources

Patients struggle with lack of consistent coverage for popular weight-loss drugs

Supplies of high-demand obesity treatments are improving, but that doesn’t mean they're easier to get. Many employers and health insurers are scaling back coverage of Wegovy or Zepbound and a

·United States
Read Full Article
The Cap TimesThe Cap Times

Medicare coverage for anti-obesity drugs would save billions

Chris Ford: As more people with commercial insurance gain access to anti-obesity medications they are poised to lose coverage upon entering Medicare.

Read Full Article
IT Supply ChainIT Supply Chain

Why More People in Sugar Land Are Turning to Medically Supervised Weight Loss - IT Supply Chain

By Rob Jackson (pictured) Content Writer The post Why More People in Sugar Land Are Turning to Medically Supervised Weight Loss appeared first on IT Supply Chain.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left
50% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

WPLG broke the news in Miami, United States on Monday, February 24, 2025.
Sources are mostly out of (0)

Similar News Topics

Diabetes

Diabetes

Wegovy

Wegovy

Obesity

Obesity

Health

Health

Medicare

Medicare

Ozempic

Ozempic

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal